Dorzolamide/Brimonidine/Timolol Impact on Ocular Surface, Glaucoma Progression & Chatbot Follow-up: GLAUCO-TECH

Clinical trial NCT07690397 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07690397
Sponsor: Tecnoquimicas
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Primary Open-Angle Glaucoma (POAG)Ocular Hypertension

Start date: 2026-06-10
Primary completion: 2027-07-10
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.